Acasti Pharma Inc.
NASDAQ:ACST
3.37 (USD) • At close October 25, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||
Current Assets: | ||||||||||||||
Cash & Cash Equivalents
| 23.005 | 27.875 | 30.339 | 50.942 | 14.24 | 16.867 | 6.367 | 2.234 | 1.047 | 0.607 | 1.169 | 1.599 | 0.329 | 0.393 |
Short Term Investments
| 0 | 0.015 | 13.322 | 9.789 | 0 | 8.886 | 0 | 5.493 | 13.644 | 20.695 | 3.505 | 5.575 | 2.564 | 0 |
Cash and Short Term Investments
| 23.005 | 27.89 | 43.661 | 60.731 | 14.24 | 25.753 | 6.367 | 7.726 | 14.692 | 21.302 | 4.674 | 7.174 | 2.894 | 0.393 |
Net Receivables
| 0.722 | 0.802 | 0.548 | 0.53 | 0.546 | 1.189 | 0 | 0 | 0.3 | 0.445 | 0.817 | 1.089 | 0.456 | 0.462 |
Inventory
| 0 | 0 | 0 | 0 | 1.098 | 0.969 | 0.314 | -0 | 0.07 | 0.235 | 0.217 | 0.603 | 0 | 0 |
Other Current Assets
| 0.283 | 0.598 | 1.072 | 1.111 | 3.676 | 1.018 | 0.395 | 0.673 | 0.509 | 1.265 | 0.033 | 0.084 | 0.015 | 0 |
Total Current Assets
| 24.01 | 29.29 | 45.531 | 62.372 | 16.079 | 27.959 | 7.35 | 8.358 | 15.699 | 23.203 | 5.724 | 8.908 | 3.365 | 0.86 |
Non-Current Assets: | ||||||||||||||
Property, Plant & Equipment, Net
| 0.024 | 0.567 | 0.315 | 0.086 | 2.057 | 2.107 | 2.184 | 0.212 | 0.056 | 0.035 | 0.019 | 0.027 | 0.039 | 0.028 |
Goodwill
| 8.138 | 8.138 | 12.964 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 41.128 | 41.128 | 69.81 | 0 | 4.244 | 5.799 | 7.794 | 10.999 | 13.984 | 17.774 | 6.145 | 6.885 | 0 | 0 |
Goodwill and Intangible Assets
| 49.266 | 49.266 | 82.774 | 0 | 4.244 | 5.799 | 7.794 | 10.999 | 13.984 | 17.774 | 6.145 | 6.885 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0.02 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| -0 | 0 | 0 | -0 | 0.473 | 0.417 | 0.43 | 1.476 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 49.29 | 49.833 | 83.089 | 0.086 | 6.774 | 8.343 | 10.428 | 12.687 | 14.04 | 17.809 | 6.164 | 6.912 | 0.039 | 0.028 |
Total Assets
| 73.3 | 79.123 | 128.62 | 62.458 | 22.853 | 36.302 | 17.778 | 21.044 | 29.739 | 41.011 | 11.888 | 15.82 | 3.403 | 0.889 |
Liabilities & Equity: | ||||||||||||||
Current Liabilities: | ||||||||||||||
Account Payables
| 1.007 | 1.242 | 1.678 | 0.115 | 1.713 | 3.047 | 2.648 | 0.277 | 0.197 | 0.287 | 0.318 | 0.552 | 0 | 0 |
Short Term Debt
| 0 | 0.075 | 0.104 | 0.086 | 0.076 | 1.361 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | -1.242 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 0.677 | 2.094 | 1.478 | 1.378 | 5.606 | 13.857 | 4.049 | 0.864 | 1.1 | 0.884 | 2.072 | 0.714 | 0.967 | 4.882 |
Total Current Liabilities
| 1.684 | 3.411 | 3.26 | 1.579 | 7.395 | 13.665 | 5.186 | 0.842 | 1.297 | 1.052 | 2.39 | 1.267 | 0.967 | 4.533 |
Non-Current Liabilities: | ||||||||||||||
Long Term Debt
| 0 | 0.41 | 0.191 | 0 | 0.071 | 0 | 1.248 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | -0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 5.514 | 7.347 | 16.889 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 4.359 | 0 | 0.01 | 5.219 | 2.393 | 12.18 | 4.976 | 0.115 | 1.884 | 10.049 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 9.873 | 7.757 | 17.09 | 5.219 | 2.464 | 12.18 | 6.224 | 0.115 | 1.884 | 10.049 | 0.318 | 0.552 | 4.274 | 0 |
Total Liabilities
| 11.557 | 11.168 | 20.35 | 6.798 | 9.859 | 25.846 | 11.41 | 0.957 | 3.181 | 11.102 | 2.39 | 1.267 | 5.241 | 4.533 |
Equity: | ||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 261.038 | 258.294 | 257.99 | 197.194 | 137.424 | 96.853 | 56.789 | 45.733 | 49.256 | 54.848 | 28.252 | 0 | 12.31 | 7.362 |
Retained Earnings
| -211.119 | -198.266 | -155.837 | -146.018 | -126.34 | -92.829 | -56.046 | -29.243 | -26.624 | -28.451 | -19.579 | -13.228 | -14.256 | -11.006 |
Accumulated Other Comprehensive Income/Loss
| -6.038 | -6.038 | -6.037 | -6.333 | -7.887 | -0.888 | -0.527 | -0.082 | -0.042 | -0.044 | -0.042 | -0.035 | -0.025 | 0 |
Other Total Stockholders Equity
| 17.862 | 13.965 | 12.154 | 10.817 | 9.797 | 10.55 | 8.009 | 21.197 | 17.325 | 10.131 | 1.558 | -0.999 | 20.114 | 0.229 |
Total Shareholders Equity
| 61.743 | 67.955 | 108.27 | 55.66 | 12.994 | 10.457 | 6.368 | 20.087 | 26.558 | 29.91 | 9.498 | 14.553 | -1.838 | -3.644 |
Total Equity
| 61.743 | 67.955 | 108.27 | 55.66 | 12.994 | 10.457 | 6.368 | 20.087 | 26.558 | 29.91 | 9.498 | 14.553 | -1.838 | -3.644 |
Total Liabilities & Shareholders Equity
| 73.3 | 79.123 | 128.62 | 62.458 | 22.853 | 36.302 | 17.778 | 21.044 | 29.739 | 41.011 | 11.888 | 15.82 | 3.403 | 0.889 |